CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-08-25 | BERGSMAN BARRY Director | Grant or award | +4,500 | $0.32 | $1K | 125,000 |
| 2008-08-22 | BERGSMAN BARRY Director | Grant or award | +10,600 | $0.34 | $4K | 107,500 |
| 2008-08-22 | BERGSMAN BARRY Director | Grant or award | +7,100 | $0.33 | $2K | 114,600 |
| 2008-08-21 | BERGSMAN BARRY Director | Grant or award | +1,900 | $0.32 | $608 | 96,900 |
| 2008-08-19 | Berg Jeffrey Alan Director | Grant or award · Common Stock | +30,000 | 30,000 | ||
| 2008-08-15 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +20,400 | $0.29 | $6K | 5,916,727 |
| 2008-08-14 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +20,000 | $0.29 | $6K | 5,896,327 |
| 2008-08-12 | Berger Kendra Chief Financial Officer | Grant or award | +18,750 | 18,750 | ||
| 2008-08-12 | Tauber Jake EVP Content & Marketing | Grant or award | +18,750 | 18,750 | ||
| 2008-08-11 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +15,100 | $0.28 | $4K | 5,876,327 |
| 2008-08-08 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +20,000 | $0.30 | $6K | 5,861,227 |
| 2008-08-01 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +1,700 | $0.30 | $510 | 5,841,227 |
| 2008-07-30 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +2,200 | $0.30 | $660 | 5,839,527 |
| 2008-07-29 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +600 | $0.30 | $180 | 5,837,327 |
| 2008-07-28 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +6,900 | $0.30 | $2K | 5,836,727 |
| 2008-07-15 | Boylan Peter James III Executive Vice President Sales | Grant or award | +18,750 | 18,750 | ||
| 2008-07-15 | Boylan Peter James III Executive Vice President Sales | Grant or award · Stock Option (Right to Buy) | +37,550 | 37,550 | ||
| 2008-06-09 | FLEMING MICHAEL K Interim CEO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2008-05-05 | BERGSMAN BARRY Director | Returned to the company · Director Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2008-04-25 | BERGSMAN BARRY Director | Grant or award · Director Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 34 of 37 · 737 trades